These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3793276)

  • 1. Short- and long-term effects of propafenone in ventricular arrhythmias.
    Gaita F; Richiardi E; Bocchiardo M; Asteggiano R; Pinnavaia A; Di Leo M; Rosettani E; Brusca A
    Int J Cardiol; 1986 Nov; 13(2):163-70. PubMed ID: 3793276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
    G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study.
    Jonason T; Ringqvist I; Bandh S; Nilsson G; Nilsson H; Lidell C; Bjerle P; Olofsson BO
    Acta Med Scand; 1988; 223(6):515-23. PubMed ID: 3291557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
    Vincenti A; Landolina M; Latini R; Cavalli A; Gaita F; Giani P
    Am Heart J; 1992 Aug; 124(2):374-80. PubMed ID: 1636581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
    Capucci A; Boriani G
    Drug Saf; 1995 Jan; 12(1):55-72. PubMed ID: 7741984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome.
    Vassiliadis I; Papoutsakis P; Kallikazaros I; Stefanadis C
    Int J Cardiol; 1990 Apr; 27(1):63-70. PubMed ID: 2335410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V; Do Ngoc D; Fidelle J; Sidi D; Batisse A; Loth P; Vrancea F; Villain E; Coumel P
    Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1385-93. PubMed ID: 3122689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P
    Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.